Canada· CA-DIN-02445530
APO-AMPHETAMINE XR
A amfetamine product containing mixed salts amphetamine, registered in Canada by APOTEX INC. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Amfetamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N06BA01 (amfetamine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Amfetamine · ATC N06BA01
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MIXED SALTS AMPHETAMINE
- Manufacturer
- APOTEX INC
- Country
- Canada (CA)
- ATC code
- N06BA01
- ATC class
- Amfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
132 interactions on record for amfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amfetamine · interactions on record
132 records
- 16 severe
- 100 moderate
- 16 info
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amfetamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9340835-adff-4b30-b21e-66770db27c9f GET /v1/drugs/e9340835-adff-4b30-b21e-66770db27c9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02445530",
"form": "CAPSULE (EXTENDED RELEASE)",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N06BA01",
"schedule": [
"Schedule G (CDSA I)"
],
"drug_code": "93081",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"MIXED SALTS AMPHETAMINE"
],
"product_categorization": null
}See everything about amfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.